328
Views
1
CrossRef citations to date
0
Altmetric
systematic review

Efficacy and tolerability of pharmacotherapy for obsessive-compulsive personality disorder: a systematic review of randomized controlled trials

ORCID Icon, , , & ORCID Icon
Pages 1351-1358 | Received 03 Feb 2022, Accepted 08 Jul 2022, Published online: 15 Jul 2022

References

  • Fineberg NA, Day GA, de Koenigswarter N, et al. The neuropsychology of obsessive-compulsive personality disorder: a new analysis. CNS Spectr. 2015;20(5):490–499.
  • Pinto A, Liebowitz MR, Foa EB, et al. Obsessive compulsive personality disorder as a predictor of exposure and ritual prevention outcome for obsessive compulsive disorder. Behav Res Ther. 2011;49(8):453–458.
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. Arlington VA: American Psychiatric Publishing; 2013.
  • Marincowitz C, Lochner C, Stein DJ. The neurobiology of obsessive-compulsive personality disorder: a systematic review. CNS Spectr. 2021 Aug;11:1–12.
  • Gecaite-Stonciene J, Lochner C, Marincowitz C, et al. Obsessive-Compulsive (Anankastic) personality disorder in the ICD-11: a scoping review. Front Psychiatry. 2021;12:30–646030.
  • Bach B, First MB. Application of the ICD-11 classification of personality disorders. BMC Psychiatry. 2018;18(1):1–14.
  • Nestadt G, Romanoski AJ, Brown C, et al. DSM-III compulsive personality disorder: an epidemiological survey. Psychol Med. 1991;21(2):461–471.
  • Grant JE, Mooney ME, Kushner MG. Prevalence, correlates, and comorbidity of DSM-IV obsessive-compulsive personality disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Psychiatr Res. 2012;46(4):469–475.
  • Ansell EB, Pinto A, Crosby RD, et al. The prevalence and structure of obsessive-compulsive personality disorder in Hispanic psychiatric outpatients. J Behav Ther Exp Psychiatry. 2010;41(3):275–281.
  • Pena-Garijo J, Edo Villamón S, Meliá de Alba A, et al. Personality disorders in obsessive-compulsive disorder: a comparative study versus other anxiety disorders. Sci World J. 2013;2013:1–7.
  • Fineberg NA, Reghunandanan S, Kolli S, et al., Obsessive-compulsive (anankastic) personality disorder: toward the ICD-11 classification. Braz J Psychiatry. 2014;36:40–50.
  • Reddy M, Vijay MS, Reddy S. Obsessive-compulsive (Anankastic) personality disorder: a poorly researched landscape with significant clinical relevance. Indian J Psychol Med. 2016;38(1):1.
  • Garyfallos G, Katsigiannopoulos K, Adamopoulou A, et al. Comorbidity of obsessive–compulsive disorder with obsessive–compulsive personality disorder: does it imply a specific subtype of obsessive–compulsive disorder? Psychiatry Res. 2010;177(1–2):156–160.
  • Albert U, Maina G, Forner F, et al. DSM-IV obsessive-compulsive personality disorder: prevalence in patients with anxiety disorders and in healthy comparison subjects. Compr Psychiatry. 2004;45(5):325–332.
  • Schiavone P, Dorz S, Conforti D, et al. Comorbidity of DSM–IV personality disorders in unipolar and bipolar affective disorders: a Comparative Study. Psychol Rep. 2004;95(1):121–128.
  • Halmi KA, Tozzi F, Thornton LM, et al. The relation among perfectionism, obsessive‐compulsive personality disorder and obsessive‐compulsive disorder in individuals with eating disorders. Int J Eating Disorders. 2005;38(4):371–374.
  • Preuss UW, Johann M, Fehr C, et al. Personality disorders in alcohol-dependent individuals: relationship with alcohol dependence severity. Eur Addict Res. 2009;15(4):188–195.
  • McGlashan TH, Grilo CM, Skodol AE, et al. The collaborative longitudinal personality disorders study: baseline axis I/II and II/II diagnostic co‐occurrence. Acta Psychiatr Scand. 2000;102(4):256–264.
  • Hummelen B, Wilberg T, Pedersen G, et al. The quality of the DSM-IV obsessive-compulsive personality disorder construct as a prototype category. J Nerv Ment Dis. 2008;196(6):446–455.
  • Rossi A, Marinangeli MG, Butti G, et al. Pattern of comorbidity among anxious and odd personality disorders: the case of obsessive-compulsive personality disorder. CNS Spectr. 2000;5(9):23–26.
  • Diedrich A, Voderholzer U. Obsessive-compulsive personality disorder: a current review. Curr Psychiatry Rep. 2015;17(2):2.
  • Mazza M, Marano G, and Janiri L. An update on pharmacotherapy for personality disorders. Expert Opin Pharmacother. 2016;17(15):1977–1979
  • Stoffers-Winterling J, Völlm B, and Lieb K. Is pharmacotherapy useful for treating personality disorders? Expert Opin Pharmacother. 2021;22(4):393–395.
  • Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.
  • Higgins J, and Altman DG. Assessing risk of bias in included studies. 2008. DOI:https://doi.org/10.1002/9780470712184.ch8.
  • Zeng X, Zhang Y, Kwong JS, et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med. 2015;8(1):2–10.
  • Singh J. Critical appraisal skills programme. J Pharmacol Pharmacother. 2013;4(1):76.
  • Taylor R, Reeves B, Ewings P, et al. A systematic review of the effectiveness of critical appraisal skills training for clinicians. Med Educ. 2000;34(2):120–125.
  • Piggott T, Morgan RL, Cuello-Garcia CA, et al. Grading of recommendations assessment, development, and evaluations (GRADE) notes: extremely serious, GRADE’s terminology for rating down by three levels. J Clin Epidemiol. 2020;120:116–120.
  • Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383–394.
  • Ekselius L, von Knorring L. Personality disorder comorbidity with major depression and response to treatment with sertraline or citalopram. Int Clin Psychopharmacol. 1998 Sep;13(5):205–11.
  • Ansseau M. Serotonergic antidepressants in obsessive-compulsive personality disorder. Obsessive-Compulsive Disorder ( Second Edition 2002;89–91.
  • Ekselius L, von Knorring L. Personality disorder comorbidity with major depression and response to treatment with sertraline or citalopram. Int Clin Psychopharmacol. 1998;13(5):205–211.
  • Diedrich A, Voderholzer U. Obsessive–compulsive personality disorder: a current review. Curr Psychiatry Rep. 2015;17(2):2.
  • Pozza A, Starcevic V, Ferretti F, et al. Obsessive-Compulsive personality disorder co-occurring in individuals with obsessive-compulsive disorder: a systematic review and meta-analysis. Harv Rev Psychiatry. 2021 Mar-Apr 01;29(2):95–107.
  • Fineberg NA, Reghunandanan S, Simpson HB, et al. Obsessive-compulsive disorder (OCD): practical strategies for pharmacological and somatic treatment in adults. Psychiatry Res. 2015;227(1):114–125.
  • York KM, Hassan M, Li Q, et al. Coronary artery disease and depression: patients with more depressive symptoms have lower cardiovascular reactivity during laboratory-induced mental stress. Psychosom Med. 2007;69(6):521–528.
  • Ipser JC, Sander C, Stein DJ. Pharmacotherapy and psychotherapy for body dysmorphic disorder. Cochrane Database Syst Rev. 2009;2009(1):Cd005332.
  • Coles ME, Pinto A, Mancebo MC, et al. OCD with comorbid OCPD: a subtype of OCD? J Psychiatr Res. 2008;42(4):289–296.
  • Nedeljkovic M, Kyrios M, Moulding R, et al. Differences in neuropsychological performance between subtypes of obsessive-compulsive disorder. Aust N Z J Psychiatry. 2009;43(3):216–226.
  • Huprich SK. Personality disorders in the ICD-11: opportunities and challenges for advancing the diagnosis of personality pathology. Curr Psychiatry Rep. 2020;22(8):40.
  • Bateman AW, Gunderson J, Mulder R. Treatment of personality disorder. Lancet. 2015;385(9969):735–743.
  • Gartlehner G, Crotty K, Kennedy S, et al. Pharmacological treatments for borderline personality disorder: a systematic review and meta-analysis. CNS Drugs. 2021 Oct;35(10):1053–1067.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.